GlobeNewswire
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
📈
AI Sentiment
Highly Positive
8/10
- Home
- HSCS
as of 02-11-2026 11:47am EST
$3.17
$0.00
-0.13%
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | SOUTHLAKE |
| Market Cap: | 11.0M | IPO Year: | 2022 |
| Target Price: | $9.20 | AVG Volume (30 days): | 30.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.78 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.01 - $6.47 | Next Earning Date: | 03-12-2026 |
| Revenue: | $8,669 | Revenue Growth: | -41.03% |
| Revenue Growth (this year): | 1072.41% | Revenue Growth (next year): | 2700.00% |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | -7511387.0 | FCF Growth: | N/A |
Latest Heart Test Laboratories Inc. News
HSCS Breaking Stock News: Dive into HSCS Ticker-Specific Updates for Smart Investing
Compare HSCS vs Leading Stocks
See how HSCS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "HSCS Heart Test Laboratories Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.